The Omicron messaging dilemma
Why public health experts believe communications around Omicron need to toe the line between too much concern and just enough.
Why public health experts believe communications around Omicron need to toe the line between too much concern and just enough.
The FDA expanded the label for Gilead’s hepatitis B drug Vemlidy on Thursday to patients as young as 6 years old. Vemlidy, or tenofovir alafenamide,…
After a better-than-expected launch, Nestlé Health Science is planning its next commercialization moves for Vowst, an oral pill to treat recurring Clostridioides difficile, or C.…
The CDC test is intended for the qualitative detection of DNA from non-variola Orthopoxvirus in human pustular or vesicular rash specimens.
The panel runs on BioMérieux’s SpotFire system for rapid point-of-care molecular diagnostic testing.
“This is not about, ‘O.K., let’s not use GLP-1s’ or anything. It’s just about, ‘let’s be careful when you’re doing procedures on these patients.’”
More than 500 cases have been reported from the island.
The Star has created an animation that shows how quickly measles can spread in an unprotected community — and why it’s important to have high…
Several outbreaks have led to an early spike in measles cases, including an ongoing outbreak in Chicago. A chart shows how the case count compares…
The trend is prompting doctors to call for more discussions with older people about sexual health.
Opinion | Surveys that assess symptoms for long Covid have been inadequate for developing a case definition for the illness.